Celecoxib—fewer gastrointestinal adverse events in patients with osteoarthritis

Access through your institution Buy or subscribe boxed-textSingh G _ et al_. (2006) Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. _Am J Med_ 119:

255–266 BACKGROUND This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and

online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes

which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Silverstein FE _

et al_. (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial.

Celecoxib Long-term Arthritis Safety Study. _JAMA_ 284: 1247–1255 Article  CAS  Google Scholar  * Bombardier C _ et al_. (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and

naproxen in patients with rheumatoid arthritis. VIGOR Study Group. _N Engl J Med_ 343: 1520–1528 Article  CAS  Google Scholar  * Schnitzer TJ _ et al_. (2004) Comparison of lumiracoxib with

naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomized controlled trial. _Lancet_ 364: 665–674

Article  CAS  Google Scholar  * Maetzel A _ et al_. (2003) The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis. _Arthritis Rheum_ 49:

283–292 Article  Google Scholar  * Cheng Y _ et al_. (2006) Cyclooxygenases, microsomal prostaglandin E synthase-I, and cardiovascular function. _J Clin Invest_ 116: 1391–1399 Article  CAS 

Google Scholar  Download references ACKNOWLEDGEMENTS The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice. AUTHOR INFORMATION AUTHORS AND AFFILIATIONS *

Professor and the Head of the Department of Rheumatology and Clinical Immunology, at the University Medical Center Utrecht, The Netherlands Johannes W J Bijlsma Authors * Johannes W J

Bijlsma View author publications You can also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Johannes W J Bijlsma. ETHICS DECLARATIONS COMPETING

INTERESTS The author declares no competing financial interests. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Bijlsma, J. Celecoxib—fewer

gastrointestinal adverse events in patients with osteoarthritis. _Nat Rev Rheumatol_ 2, 414–415 (2006). https://doi.org/10.1038/ncprheum0251 Download citation * Received: 24 April 2006 *

Accepted: 12 June 2006 * Issue Date: August 2006 * DOI: https://doi.org/10.1038/ncprheum0251 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content:

Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative